Health ❯Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Alzheimer's Disease Cancer Drugs Market Competition Oncology Regulatory Affairs ALS Treatment Biotechnology Innovative Therapies Pain Management Weight Loss Obesity Treatments Animal Testing Targeted Therapies Antibiotic Discovery Antibiotic Resistance Biopharmaceuticals Eli Lilly Active Ingredients Moderna Regulatory Approval Monoclonal Antibody Therapy Aging Interventions Antifungal Drugs AstraZeneca Clinical Development Life-Saving Drugs Protein Therapeutics Nanotechnology Drug Design Regulatory Issues Clinical Research GLP-1 Drugs Tirzepatide Vaccines Fluorinated Compounds Cancer Treatments Novel Therapies Addiction Treatment New Medications Stability Enhancement Cardiometabolic Diseases Market Potential Antidotes Clinical Use Vaccine Manufacturing First-in-Class Medications Stroke Prevention Compounding Pharmacy New Treatments Telomerase Inhibitors Amyloid-Removing Drugs Monoclonal Antibodies Antiparasitic Drugs Respiratory Diseases Clinical Efficacy Lifespan Extension Cancer Generic Drugs Antiviral Drugs Liver Condition Treatment Liver Disease Drugs Drug Formulation Antibiotics Testing Procedures Revenue Targets Diabetes Treatment Heart Failure Drug Epilepsy Treatment Therapies Weight-Loss Pill Modified Release Formulation Weight Loss Medications Pricing Strategies Long-term Effects Therapeutics Alzheimer's Treatments Diabetes Drugs Targeted Therapy Molecular Therapy

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

European pharmaceutical leaders warn that strict price controls and tariff uncertainty are driving billions in R&D and manufacturing investments to the U.S., threatening EU health sovereignty.

Senolytic Drugs Clear 'Zombie Cells,' Offer New Hope for Chronic Back Pain Treatment

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Boehringer Ingelheim Reports Strong 2024 Growth and Prepares for New Product Launches in 2025

Nitisinone Identified as Promising Mosquito-Killing Tool in Malaria Fight

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

Cargo Therapeutics Ceases Operations Following Clinical and Financial Setbacks

Ebola Pill Shows Promise in Monkey Trials, Raising Hopes for Human Treatment

Annual HIV Prevention Injection Shows Promise in Early Safety Trials

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

FDA Approves Journavx, First Non-Opioid Painkiller in Over Two Decades

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

New Drug Regimens Revolutionize Treatment for Drug-Resistant Tuberculosis

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End

AI-Designed Proteins Show Promise in Neutralizing Snake Venom Toxins

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Galapagos Announces Plan to Split Into Two Public Companies by Mid-2025

Scientists Discover Faster mRNA Degradation Process Linked to Key Cellular Functions

Breakthrough Drug Delivery System Crosses Blood-Brain Barrier

Eli Lilly's Oral Drug Shows Promise in Lowering Genetic Cholesterol

DeepMind's AlphaFold 3 Goes Open Source, Boosting Drug Discovery

Caterpillar Fungus Compound Shows Promise in Slowing Cancer Cell Growth

Caterpillar Fungus Shows Promise in Cancer Treatment

EU Fines Teva $503 Million for Blocking MS Drug Competition

Eli Lilly Sues Vendors for Selling Unauthorized Tirzepatide Products

Xenon Pharmaceuticals to Showcase at BofA CNS Therapeutics Conference

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

Moderna's mRNA Vaccine Shows Superior Mpox Protection in Animal Studies

Sea Snail Venom Offers New Hope for Diabetes Treatment

Scientists Discover New Antibiotics in Human Gut Microbiome

Breakthrough in Understanding Protein Quality Control Mechanism

UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

Eli Lilly Acquires Morphic for $3.2 Billion

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock

Breakthrough in Male Birth Control: Reversible, Non-Hormonal Pill Shows Promise

Cytokinetics' $575M Royalty Deal Faces Investor Backlash

AstraZeneca Targets $80 Billion Revenue by 2030 with 20 New Medicines

Experts Warn of Superbugs Potentially Surpassing COVID-19 Impact

Varda Space Industries Secures $90 Million for Space-Based Drug Manufacturing Expansion

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Vertex's Non-Opioid Painkiller Shows Promising Results in Mid-Stage Trial

Loyal's Life-Extending Drug for Large Dogs Receives Conditional FDA Approval